Lv1
70 积分 2023-07-02 加入
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
2天前
已完结
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2天前
已完结
Multiple myeloma: Role of autologous transplantation
3天前
已完结
Rituximab, Dexamethasone, Cytarabine, and Oxaliplatin (R-DHAX) Is an Effective and Safe Salvage Regimen in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
5天前
已完结
A retrospective study of R‐DHAP/Ox for early progressing follicular lymphoma
6天前
已关闭
How I treat early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) in children
1个月前
已完结
A review of treatment options employed in relapsed/refractory AML
1个月前
已完结
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
1个月前
已完结
[Venetoclax Combined with CACAG Regimen in the Treatment of Patients with Refractory/Relapse Acute Myeloid Leukemia: A Prospective Clinical Study]
1个月前
已关闭
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML
1个月前
已完结
皖公网安备34019202002308
